We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
144 hedge funds and large institutions have $910M invested in Atara Biotherapeutics in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,322% more call options, than puts
Call options by funds: $1.55M | Put options by funds: $109K
35% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 17
18% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 44
4% more funds holding
Funds holding: 139 → 144 (+5)
0.1% less ownership
Funds ownership: 4.31% → 4.21% (-0.1%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
39% less capital invested
Capital invested by funds: $1.5B → $910M (-$590M)
Holders
144
Holders Change
+5
Holders Change %
+3.6%
% of All Funds
2.27%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
23
Increased
52
Reduced
44
Closed
17
Calls
$1.55M
Puts
$109K
Net Calls
+$1.44M
Net Calls Change
+$693K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$24.8M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$22.9M |
| 3 |
Goldman Sachs
New York
|
+$13.7M |
| 4 |
JP Morgan Chase
New York
|
+$9.84M |
| 5 |
Renaissance Technologies
New York
|
+$7.26M |
Top Sellers
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$15.5M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$11.8M |
| 3 |
BM
Bridger Management
New York
|
-$9.72M |
| 4 |
N
Natixis
Paris,
France
|
-$7.32M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.5M |
